Non-canonical PD-1 signaling in cancer and its potential implications in clinic

Non-canonical PD-1 signaling in cancer and its potential implications in clinic

Programmed cell death 1 (PD-1)-based immunotherapy has revolutionized the treatment of various cancers. However, only a certain group of patients benefit from PD-1 blockade therapy and many patients succumb to hyperprogressive disease. Although, CD8 T cells and conventional T cells are generally con...

Full description

Bibliographic Details
Main Authors: Haoran Zha, Zhihua Li, Juan An, Xiaochun Zhang, Huoming Chen, Zhaoxia Li
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/2/e001230.full

Similar Items

Similar Items